Cofactor Genomics is bridging the precision medicine gap by building diagnostic tools to match the right patient to the right treatment at the right time. Predicting patient response currently relies on isolated, single-analyte biomarkers that have failed to deliver accurate therapy response predictions, resulting in unnecessary healthcare costs, and most harmfully, negative outcomes for patients. Cofactor’s products use Predictive Immune Modeling, which leverages RNA data and machine learning to combine biological signals, creating multidimensional biomarkers to deliver on the promise of precision medicine. Cofactor Genomics offers its full-service molecular, informatic, and database tools to make drug discovery, clinical trials and therapy selection more successful.

Biotechnology

Education

Health & Wellness

Cofactor Genomics

Jarret Glasscock

Kevin Flanagan

Eric Duncavage

The leadership team at Cofactor Genomics has a wealth of experience in the medical and academic fields, as well as in venture capital and industry. Members of the team have worked as a Medical Director, a Professor of Pathology and Immunology, an Instructor, and a Pre-doctoral fellow, among other positions. They have also been active in the community, serving on the Industry Advisory Board at SLU and as a Principal at Corvus Research Group. In addition to their impressive work histories, the team is also highly educated, with degrees from Washington University School of Medicine in St. Louis, the University of Utah School of Medicine, and Washington University in St. Louis.

Leadership Team

About

Team members